Taken together, the findings of this study assert that a dysregulated metabolic state is a distinct feature of CSC-enriched luminal and basal breast cancer subtypes and that in particular; the enzyme HMGCS1 is a novel and potential general marker of this enrichment. Here, HMGCS1 is linked to breast cancer.